Abstract
The molecular biology of aging has always been of extreme interest to researchers. Recent advances made through studies of model systems have greatly increased efforts to elucidate the mechanisms involved in aging. It now appears that in yeast there are two pathways controlling aging: i) the generation of extrachromosomal rDNA circles (ERCs) through the antagonistic action of Sir2p and Fob1p; and ii) the stress response pathway, regulated by the Sch9p and Tor1p kinases. The stress response pathway in higher eukaryotes is inhibited by the insulin-signaling pathway. Mutation to the AKT kinase disrupts insulin signaling and increases longevity. Yeast express orthologues of the insulin-signaling pathway, yet insulin is not a natural substrate for yeast. The yeast Sch9p is structurally and functionally related to the AKT kinase, but the remainder of the putative yeast AKT pathways is uncharacterized. Further mystery revolves around downstream targets that are directly required for longevity. Yeast provide an opportunity to investigate the function of the yeast AKT pathway at a molecular level. A potential downstream target has been identified in yeast that links the glucose and stress response pathways with lifespan: the Anaphase Promoting Complex (APC). This review will discuss the role the APC plays in established aging pathways in yeast and the implications on higher eukaryotes.
Keywords: Anaphase Promoting Complex, stress response pathway, caloric restriction, evolutionary conservation
Current Genomics
Title: The Anaphase Promoting Complex and Aging: The APCs of Longevity
Volume: 7 Issue: 4
Author(s): Troy A. A. Harkness
Affiliation:
Keywords: Anaphase Promoting Complex, stress response pathway, caloric restriction, evolutionary conservation
Abstract: The molecular biology of aging has always been of extreme interest to researchers. Recent advances made through studies of model systems have greatly increased efforts to elucidate the mechanisms involved in aging. It now appears that in yeast there are two pathways controlling aging: i) the generation of extrachromosomal rDNA circles (ERCs) through the antagonistic action of Sir2p and Fob1p; and ii) the stress response pathway, regulated by the Sch9p and Tor1p kinases. The stress response pathway in higher eukaryotes is inhibited by the insulin-signaling pathway. Mutation to the AKT kinase disrupts insulin signaling and increases longevity. Yeast express orthologues of the insulin-signaling pathway, yet insulin is not a natural substrate for yeast. The yeast Sch9p is structurally and functionally related to the AKT kinase, but the remainder of the putative yeast AKT pathways is uncharacterized. Further mystery revolves around downstream targets that are directly required for longevity. Yeast provide an opportunity to investigate the function of the yeast AKT pathway at a molecular level. A potential downstream target has been identified in yeast that links the glucose and stress response pathways with lifespan: the Anaphase Promoting Complex (APC). This review will discuss the role the APC plays in established aging pathways in yeast and the implications on higher eukaryotes.
Export Options
About this article
Cite this article as:
A. Harkness A. Troy, The Anaphase Promoting Complex and Aging: The APCs of Longevity, Current Genomics 2006; 7 (4) . https://dx.doi.org/10.2174/138920206778426997
DOI https://dx.doi.org/10.2174/138920206778426997 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inflammasome and Atherogenesis
Current Pharmaceutical Design Template Dependent Human DNA Polymerases
Current Topics in Medicinal Chemistry Intraocular Immune Mechanisms in Uveitis
Current Immunology Reviews (Discontinued) Obesity: An Emerging Importance of Progenitors
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pharmacogenetically Tailored Treatments for Heart Disease
Current Pharmaceutical Design The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews A New Binding Site Involving the C-terminal Domain to Design Specific Inhibitors of PepX
Protein & Peptide Letters Parathyroid Hypertension: A Rare, but Curable form of Secondary Hypertension
Current Hypertension Reviews Rheumatoid Arthritis in Southern Europe: Epidemiological, Clinical, Radiological and Genetic Considerations
Current Rheumatology Reviews Genetic Variation in the β2-Adrenergic Receptor: Impact on Intermediate Cardiovascular Phenotypes
Current Pharmacogenomics and Personalized Medicine The Effects of Incretins on Energy Homeostasis: Physiology and Implications for the Treatment of Type 2 Diabetes Mellitus and Obesity
Current Vascular Pharmacology Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists
Current Pharmaceutical Design Neuropeptides and Other Chemical Mediators, and the Role of Anti-inflammatory Drugs in Primary Headaches
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Omalizumab for Asthma: Indications, Off-Label Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
Current Cancer Drug Targets The Efficacy of Conceptual DFT Descriptors and Docking Scores on the QSAR Models of HIV Protease Inhibitors
Medicinal Chemistry Assembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers Disease
Current Alzheimer Research Immunomodulatory Therapy Associated to Anti-Parasite Drugs as a Way to Prevent Severe Forms of Malaria
Current Clinical Pharmacology GapMis: a Tool for Pairwise Sequence Alignment with a Single Gap
Recent Patents on DNA & Gene Sequences Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology